T1	Participants 1098 1450	Patients presenting within 6 h of onset of STEMI and undergoing planned primary PCI (P-PCI) with TIMI 0/1 flow in the infarct-related artery (IRA) and no significant bystander coronary artery disease on angiography, are randomised into one of three groups: PCI with adjunctive pharmacotherapy (intracoronary adenosine or SNP) or control (standard PCI).
T2	Participants 1895 1973	recruit 240 patients (powered at 80% to detect a 5% absolute reduction in IS).
